advertisement
11.3.4 Betablocker (48)
Showing records 1 to 25
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker74819 Acute hypotony maculopathy following the initiation of a topical aqueous suppressant in a patient with a history of panuveitis without prior filtering surgery
Zhu D
American journal of ophthalmology case reports 2017; 7: 95-98
74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Nagai N
Experimental Eye Research 2017; 165: 118-124
74332 A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension
Dixon ER
Journal of AAPOS 2017; 21: 370-374.e1
74099 Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure
Sifaoui I
Experimental parasitology 2017; 183: 117-123
74715 Glaucoma drug therapy in pregnancy: literature review and Teratology Information Service (TIS) case series
Pellegrino M
Current drug safety 2018; 13: 3-11
74233 Selective Laser Trabeculoplasty vs. Fixed Combinations with Timolol in Practice: A Replacement Study in Primary Open Angle Glaucoma
Tufan AK
Turkish journal of ophthalmology 2017; 47: 198-204
74071 Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study
Rolle T
BMC Ophthalmology 2017; 17: 136
74332 A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension
Landry T
Journal of AAPOS 2017; 21: 370-374.e1
74715 Glaucoma drug therapy in pregnancy: literature review and Teratology Information Service (TIS) case series
D Oria L
Current drug safety 2018; 13: 3-11
74233 Selective Laser Trabeculoplasty vs. Fixed Combinations with Timolol in Practice: A Replacement Study in Primary Open Angle Glaucoma
Onur İU
Turkish journal of ophthalmology 2017; 47: 198-204
74071 Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study
Spinetta R
BMC Ophthalmology 2017; 17: 136
74099 Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure
Reyes-Batlle M
Experimental parasitology 2017; 183: 117-123
74819 Acute hypotony maculopathy following the initiation of a topical aqueous suppressant in a patient with a history of panuveitis without prior filtering surgery
Ameri H
American journal of ophthalmology case reports 2017; 7: 95-98
74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Ogata F
Experimental Eye Research 2017; 165: 118-124
74332 A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension
Venkataraman S
Journal of AAPOS 2017; 21: 370-374.e1
74099 Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure
López-Arencibia A
Experimental parasitology 2017; 183: 117-123
74819 Acute hypotony maculopathy following the initiation of a topical aqueous suppressant in a patient with a history of panuveitis without prior filtering surgery
Reznik A
American journal of ophthalmology case reports 2017; 7: 95-98
74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Otake H
Experimental Eye Research 2017; 165: 118-124
74233 Selective Laser Trabeculoplasty vs. Fixed Combinations with Timolol in Practice: A Replacement Study in Primary Open Angle Glaucoma
Yiğit FU
Turkish journal of ophthalmology 2017; 47: 198-204
74071 Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study
Nuzzi R
BMC Ophthalmology 2017; 17: 136
74715 Glaucoma drug therapy in pregnancy: literature review and Teratology Information Service (TIS) case series
De Luca C
Current drug safety 2018; 13: 3-11
74099 Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure
Wagner C
Experimental parasitology 2017; 183: 117-123
74715 Glaucoma drug therapy in pregnancy: literature review and Teratology Information Service (TIS) case series
Chiaradia G
Current drug safety 2018; 13: 3-11
74332 A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension
Gustafson N
Journal of AAPOS 2017; 21: 370-374.e1
74819 Acute hypotony maculopathy following the initiation of a topical aqueous suppressant in a patient with a history of panuveitis without prior filtering surgery
Rao NA
American journal of ophthalmology case reports 2017; 7: 95-98
